Weisblum Eric 4
4 · Silo Pharma, Inc. · Filed Nov 22, 2024
Insider Transaction Report
Form 4
Weisblum Eric
DirectorPres, Chief Compliance Officer
Transactions
- Purchase
Common Stock
2024-11-22$0.90/sh+2,500$2,250→ 185,432 total - Purchase
Common Stock
2024-11-20$0.95/sh+2,500$2,375→ 182,932 total